MORELLO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 4.301
AS - Asia 2.784
EU - Europa 2.631
SA - Sud America 494
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 86
OC - Oceania 13
Totale 10.442
Nazione #
US - Stati Uniti d'America 4.149
SG - Singapore 1.134
IT - Italia 1.000
CN - Cina 653
BR - Brasile 398
PL - Polonia 314
DE - Germania 271
HK - Hong Kong 255
FI - Finlandia 219
VN - Vietnam 208
BD - Bangladesh 177
UA - Ucraina 165
FR - Francia 151
GB - Regno Unito 123
RU - Federazione Russa 99
IN - India 84
CA - Canada 81
TR - Turchia 80
IE - Irlanda 50
NL - Olanda 45
SE - Svezia 45
MX - Messico 40
CZ - Repubblica Ceca 31
JP - Giappone 29
ES - Italia 28
IQ - Iraq 28
AR - Argentina 24
ID - Indonesia 23
ZA - Sudafrica 23
BE - Belgio 21
EC - Ecuador 18
CO - Colombia 15
TH - Thailandia 14
AT - Austria 13
PK - Pakistan 13
VE - Venezuela 13
AU - Australia 12
MA - Marocco 12
MY - Malesia 12
EG - Egitto 11
ET - Etiopia 10
PT - Portogallo 10
GR - Grecia 9
JM - Giamaica 8
PY - Paraguay 8
PH - Filippine 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
DZ - Algeria 6
PE - Perù 6
UY - Uruguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
CR - Costa Rica 5
DK - Danimarca 5
GH - Ghana 5
GT - Guatemala 5
IR - Iran 5
JO - Giordania 5
KE - Kenya 5
CL - Cile 4
LK - Sri Lanka 4
LT - Lituania 4
NO - Norvegia 4
NP - Nepal 4
TW - Taiwan 4
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TN - Tunisia 3
UG - Uganda 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
EE - Estonia 1
HN - Honduras 1
LB - Libano 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
Totale 10.304
Città #
Singapore 664
Ashburn 461
San Jose 389
Warsaw 303
Hong Kong 251
Fairfield 238
New York 205
The Dalles 178
Beijing 158
Helsinki 154
Brescia 153
Woodbridge 149
Chandler 139
Los Angeles 130
Jacksonville 125
Seattle 120
Munich 115
Houston 111
Ann Arbor 109
Dallas 105
Milan 104
Wilmington 93
Lauterbourg 81
Princeton 77
Council Bluffs 74
Rome 68
Des Moines 67
Cambridge 66
Ho Chi Minh City 60
Columbus 55
Istanbul 54
Santa Clara 50
Boardman 49
Dublin 49
Hanoi 46
Shanghai 45
São Paulo 44
Turku 43
Buffalo 39
Chicago 39
San Francisco 39
Moscow 33
Redondo Beach 29
Naples 28
Orem 27
Toronto 26
Nanjing 25
Frankfurt am Main 24
Tokyo 24
London 23
Brno 22
Nuremberg 22
Brooklyn 21
Phoenix 21
Chennai 20
Montreal 20
Turin 20
Brussels 19
Charlotte 19
Mexico City 19
Denver 18
Stockholm 18
Florence 16
Tianjin 16
Boston 15
Johannesburg 15
Poplar 15
Atlanta 14
Changsha 14
Pune 14
Verona 14
San Diego 13
Amsterdam 12
Baghdad 12
Bari 12
Lappeenranta 12
Mumbai 12
Paris 12
Jinan 11
Manchester 11
Barlassina 10
Wroclaw 10
Addis Ababa 9
Guayaquil 9
Haiphong 9
Newark 9
Pavia 9
Shenyang 9
Alessandria 8
Belo Horizonte 8
Bergamo 8
Da Nang 8
Romola 8
Bangkok 7
Bologna 7
Bosio 7
Brasília 7
Cagliari 7
Gorlago 7
Guangzhou 7
Totale 6.380
Nome #
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 295
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 293
Malnutrizione, valutazione nutrizionale e aspetti dietetici 233
OUR FOOD, OUR HEALTH: NOURISHING BIODIVERSITY TO HEAL OURSELVES AND THE PLANET Slow Food’s Position Paper on Food and Health 215
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 210
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults 208
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 199
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 192
Advances in CMV Management: A Single Center Real-Life Experience 177
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 172
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 171
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 166
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 166
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 161
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 159
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 156
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 155
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 149
A Case of Spondyloarthritis in Patient Affected by Unicentric Castleman's Disease Effectively Managed with Surgery Resection and Tocilizumab Treatment 149
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 148
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 146
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study 146
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 146
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 144
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 140
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 137
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 133
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 132
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 131
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 131
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 131
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 130
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 130
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 130
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 129
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 128
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 127
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 126
Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm. 125
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 123
POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS 122
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 121
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. 120
A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation 120
P. aeruginosa bloodstream infections among hematological patients: an old or new question? 119
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 115
Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS) 115
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 113
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 113
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 112
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 111
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 110
Nutritional strategies to improve VRE control 110
Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study 107
Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial 106
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 105
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 105
Neuro-toxoplasmosis in haploidentical haematopoietic stem cell transplant 104
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin's lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability 103
RIC Allogeneic Transplantation Improves the Overall and Progression-Free Survival of Hodgkin Lymphoma Patients Relapsing after Autologous Transplantation: A GITMO Retrospective Study Based on Time of HLA-Typing and Donor Availability. 102
Impact of transforming growth factor-β2 enriched food for special medical purposes on nutritional status, microbiota and clinical outcomes after allogeneic hematopoietic stem cell transplantation: prospective analysis of 192 consecutive patients 101
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 100
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 100
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 100
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 99
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 98
Management of invasive infections due to a rare arthroconidial yeast, saprochaete capitata, in two patients with acute hematological malignancies 88
Real-world outcomes of total body irradiation-based conditioning in allogeneic hematopoietic stem cell transplantation: A single-center retrospective study 83
I diritti del malato 80
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 79
Aspetti Clinici della cGVHD polmonare 78
Isolated Cerebral Myeloid Sarcoma in an Allogeneic Stem Cell Transplant Recipient 77
Superiority of RIC allogeneic transplantation over conventional treatment for HL patients relapsing after autologous transplantation: a GITMO retrospective study based on time of HLA-typing and donor availability. 75
MALNUTRITION AND GVHD IN ALLOGENIC BONE MARROW TRANSPLANTATION: A PROSPECTIVE STUDY 74
Moving the Care Process in the in-Home Context: The Therapeutic Prescription 70
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group 70
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases 64
A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the “Gut Fitness”? 61
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 54
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 42
Psychosocial well-being in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) and their caregivers: A prospective study 37
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 36
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 32
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 28
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission 18
Calcineurin inhibitor-induced pain syndrome: an uncommon side effect of immunosuppressive therapy after allogeneic hematopoietic stem cell transplant. a case report and review of the literature 8
Cytokine Release Syndrome after Haploidentical Transplantation is Associated with Improved Survival Without Increasing Transplant-Related Mortality 8
The role of physical therapy across the transplant trajectory in allogeneic hematopoietic stem cell transplantation, a systematic review and clinical framework 7
Correction: Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50 (Cancers, (2025), 17, 20, (3278), 10.3390/cancers17203278) 3
Totale 10.442
Categoria #
all - tutte 47.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022350 0 31 7 29 11 33 16 32 18 64 28 81
2022/2023451 54 12 18 40 44 99 3 54 53 13 30 31
2023/2024675 40 16 55 38 34 156 28 26 118 9 17 138
2024/20252.054 41 54 24 188 178 165 135 132 323 181 350 283
2025/20264.794 357 419 289 577 483 404 803 245 322 446 233 216
2026/2027354 232 122 0 0 0 0 0 0 0 0 0 0
Totale 10.442